Vericel Q2 revenue rises 20% to $63.2 million; net loss narrows to $0.6 million
Vericel reported second quarter 2025 results for the period ended June 30, 2025, with total revenue up 20% to $63.2 million and a net loss of $0.6 million, or $0.01 per diluted share, versus $4.7 million a year earlier. The company reaffirmed its full-year MACI revenue growth and profitability guidance, which matters to shareholders because it shows revenue and earnings improving while the outlook was held steady.
Key points
- Total net revenue rose to $63.2 million from $52.7 million; MACI net revenue grew 21% to $53.5 million.
- Gross margin was 74%, up from 70% a year earlier; non-GAAP adjusted EBITDA rose 112% to $13.4 million.
- Full-year 2025 guidance was reaffirmed for MACI revenue growth in the low 20% range and for a 74% gross margin and 26% adjusted EBITDA margin.
- As of June 30, 2025, the company had approximately $164 million in cash and investments and no debt.
The filing
Written by AI on Nov 8, 2026, 1:49 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on July 31, 2025.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.